Contract Services Methods Development
Bridgewest Group launches NovaCina, new sterile injectable CDMO
The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...
April 05, 2023 | News
Cambrex Opens New Stability Storage Facility in Belgium
Strategically located in the Liège region and approximately 90 kilometers from Brussels, the new state-of-the-art temperature-controlled and mo...
April 04, 2023 | News
Evonik breaks ground on $220 million Lipid Innovation Center
Facility to secure global supply of functional excipients for RNA medicines Cooperative agreement with U.S. Government to advance U.S. biopharma industr...
March 30, 2023 | News
Hovione and Ripple Partner to Expand Epidel® Platform Beyond Ophthalmology.
The core feature of Ripple's Epidel® technology is the ability to deliver sustained-release pharmaceuticals with surface erosion release kinetics witho...
March 21, 2023 | News
Samsung Biologics to build Plant 5 for Bio Campus II expansion.
The company plans to begin construction in the first half of 2023 and commence operations in 2025 As part of Samsung Biologics' second Bio Campus, ...
March 17, 2023 | News
AtomVie Global Radiopharma builds industry-leading CDMO facility in Ontario.
Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organi...
March 02, 2023 | News
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center
The additional investment for the ‘R&PD Center’ was confirmed by the board of directors committee with a total of 261 million USD SK bio...
February 08, 2023 | News
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
Clinical development pipeline is essential to global business strategy Vetter Development Service offers comprehensive expertise for in-human trial mate...
February 02, 2023 | News
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...
January 11, 2023 | News
WuXi STA Launches First Continuous Manufacturing Line for Oral Solids
WuXi STA’s continuous manufacturing line features continuous direct compression equipment with unit operations including dispensing, blending, lubric...
January 04, 2023 | News
GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development
According to the collaboration agreements, WuXi XDC will actively promote GeneQuantum’s proprietary iLDC (intelligent Ligase-dependent Conjugation) a...
December 28, 2022 | News
WuXi STA Launches Another Parenteral Formulation Manufacturing Line at Wuxi city site
This new line features a fully automatic vial loading/unloading system and a built-in 15 m2 lyophilizer in a fully enclosed isolator. The filling line...
December 01, 2022 | News
WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility
WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...
November 24, 2022 | News
CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
New research from the CPHI Annual Report 2022 – launched during CPHI Frankfurt (1-3 November, 2022) – predicts that huge volumes of V...
October 28, 2022 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
